Accendra Health, Inc. (ACH) Misses Q2 EPS by 31c ; Offers Guidance

Accendra Health, Inc. (NYSE: ACH) reported Q2 EPS of ($0.19), $0.31 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $613.2 million versus the consensus estimate of $632.21 million.

FY 2026 Outlook:-
Revenue between $2.45 billion - $2.55 billion vs consensus $2.57 billion.

For earnings history and earnings-related data on Accendra Health, Inc. (ACH) click here.

You May Also Be Interested In

• Microsoft plans data center push to triple its computing power - Bloomberg
• Wedbush Assumes Tenable (TENB) at Underperform
• RH (RH) Tops Q2 EPS by $2.31